Sclerostin does not play a major role in the pathogenesis of skeletal complications in type 2 diabetes mellitus

Pereira, M; Gohin, S; Lund, N; Hvid, A; Smitham, P J; Oddy, M J; Reichert, I; Farley, D; Roux, J P; Cleasby, M E; Chenu, C

doi:10.1007/s00198-016-3718-0

Sclerostin does not play a major role in the pathogenesis of skeletal complications in type 2 diabetes mellitus

Pereira, M; Gohin, S; Lund, N; Hvid, A; Smitham, P J; Oddy, M J; Reichert, I; Farley, D; Roux, J P; Cleasby, M E; Chenu, C

Authors

M Pereira

S Gohin

N Lund

A Hvid

P J Smitham

M J Oddy

I Reichert

D Farley

J P Roux

M E Cleasby

C Chenu

Citation

Pereira, M., Gohin, S., Lund, N., Hvid, A., Smitham, P. J., Oddy, M. J., Reichert, I., Farley, D., Roux, J. P., Cleasby, M. E., & Chenu, C. (2017). Sclerostin does not play a major role in the pathogenesis of skeletal complications in type 2 diabetes mellitus. Osteoporosis International, 28(1), 309-320. https://doi.org/10.1007/s00198-016-3718-0

Journal Article Type	Article
Acceptance Date	Jul 20, 2016
Publication Date	Jan 1, 2017
Deposit Date	Nov 17, 2016
Publicly Available Date	Nov 17, 2016
Journal	Osteoporosis International
Print ISSN	0937-941X
Electronic ISSN	1433-2965
Publisher	Springer
Peer Reviewed	Peer Reviewed
Volume	28
Issue	1
Pages	309-320
DOI	https://doi.org/10.1007/s00198-016-3718-0
Public URL	https://rvc-repository.worktribe.com/output/1394158